Byfavo (remimazolam)
MarketedA general anaesthetic approved and launched in Korea, made at the company's Hagil plant.
FROM PUBLIC EVENTS · 2026-11-15
Late clinical · capacity Expanding injectable production with a new Pyeongtaek plant alongside sales of its general anaesthetic.
Roles often seen at this stageManufacturing & MSAT · Quality QA & QC · Sales & marketing
A pharmaceutical company producing and selling injectables centred on anaesthetics and cardiovascular drugs, including the general anaesthetic Byfavo.
A general anaesthetic approved and launched in Korea, made at the company's Hagil plant.
Is investing in a new Pyeongtaek plant to expand injectable production.
Official role guide
Observed 2026-11-15
Information from a role guide does not establish a current vacancy.
A brief based on selected official material, not an exhaustive product or vacancy list.